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Abstract
Background: Repairing the tricuspid valve in patients undergoing left heart valve surgery is still controversial. Severe Tricuspid
regurge is repaired by most surgeons, while moderate regurge is frequently unaddressed. Another controversy is the technique of
repair. DeVega technique is widely used; still, the longevity of this repair is still questioned. The risk of its early failure and
subsequent recurrence of significant regurge requiring redo surgery has led many surgeons to adopt the use of annuloplasty rings.
The aim of our study was to assess the short term results (1 year) of tricuspid repair with or without ring annuloplasty.
Patients and methods: 80 patients who had tricuspid repair concomitantly with mitral valve surgery at Cairo University Hospitals
over 5 years were studied by echocardiography at discharge and at 1 year after surgery.
Results: 62 patients had repair using the DeVega annuloplasty (group A) while 18 had ring annuloplasty (group B). The mean age
was 33 ± 6 years and 37 ± 8 years for group A and B respectively. The cardiopulmonary bypass (CPB) time was relatively longer in
group B. There was only one mortality in group A. Echocardiography done for all patients of both groups at discharge and at 1 year
postoperatively showed no significant difference between both groups.
Conclusion: Tricuspid repair using ring annuloplasty has good results but with no significant benefits over DeVega annuloplasty at
one year.
Copyright © 2016, The Egyptian Society of Cardio-thoracic Surgery. Publishing services by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Repairing the tricuspid valve in patients undergoing left side valve surgery (mitral or aortic) is still controversial.
Most surgeons perform tricuspid repair only for severe tricuspid regurge. Moderate Tricuspid regurge, often secondary
to annular dilatation following right ventricular enlargement due to left side pathology is not attacked by most* Corresponding author. Fayoum University, 417, Abdelmoneem Riad st, 6 October, Guiza, Egypt.
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impairing the right ventricular (RV) function by time. These patients are usually managed by diuresis and only
considered for Tricuspid valve replacement after advanced RV dysfunction has developed. By that time, Tricuspid
valve surgery carries very high risk of morbidity and mortality [1].
The American College Of Cardiology/American Heart Association (ACC/AHA) as well as the European Society
Of Cardiology (ESC) have agreed on performing Tricuspid repair for severe Tricuspid regurge in patients who are
undergoing mitral valve surgery as a class one indication [2,3].
Another controversy is the technique of repair. The well-known DeVega procedure (single poly propylene suture
from the anteroseptal to the posteroseptal commissure with a pledget at each end) or a modified DeVega (pledget
placement between each entry site into the annulus), is widely used with accepted results by many surgeons. It is a
simple and moreover economic procedure. The longevity of the outcome of this technique highly questioned the risk
off its failure with subsequent development of significant tricuspid regurgitation requiring a redo surgery. This has led
many surgeons to adopt the use of annuloplasty rings.
The aim of our study was to assess the short term results (one year) of tricuspid repair with or without ring annuloplasty.
2. Patients and methods
We studied the outcome of 80 patients who had concomitant tricuspid valve repair for severe tricuspid regurgitation
with mitral valve surgery at Cairo University Hospitals from 2010 to 2015. This retrospective study was performed
including all patients who underwent this procedure during this period of time. Patients with concomitant aortic pa-
thology, ischemic heart disease needing coronary artery bypass grafting (CABG) and redo cases were excluded. The
studied patients were divided into two groups: Group (A) included 62 patients who had tricuspid repair using the DeVega
technique, while group (B) included 18 patients who had ring annuloplasty.
2.1. Preoperative data
The following table (Table 1), represents the preoperative criteria for both groups.Table 1
Preoperative data.
Group A Group B P value
Number of patients 62 18
Females 63% 68% >0.05 (NS)
Mean age 33 ± 6 years 37 ± 8 years >0.05 (NS)2.2. Operative technique
All patients were done via median sternotomy. Myocardial protection was done using antegrade cold blood car-
dioplegia via the aortic root with systemic cooling to 28 C and topical cooling using ice slush. Mitral valve repair was
done in 10 patients from group A and 3 patients from group B. Repair was usually done using the CarpentiereEdwards
ring. The remaining patients had mitral valve replacement. After closure of the left atrium, deairing, and removal of theTable 2
Operative data.
Group A (62 patients) Group B (18 patients) P value
Mitral repair 10 3
Mitral replacement 52 15
Mechanical # 27 18 3
Mechanical # 29 23 10
Mechanical # 31 8 2
Tissue valve 3 e
Cross-clamp time 60 ± 4 min 58 ± 3 min >0.05
CPB time 90 ± 32 min 110 ± 21 min <0.05(S)
There were no significant differences between both groups regarding the cross-clamp time. The CPB time was however longer in the ring annu-
loplasty group.
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the degree of tricuspid regurge was usually done by intraoperative transesophageal echocardiography (TEE) prior to
CPB. InGroupB patients, tricuspid repair was done using the CarpentiereEdwards ring in 14 patients. In the remaining
4 patients, the Cosgrove flexible ring was used. The following table shows the operative data for both groups (Table 2).
2.3. Statistical analysis
All data were described as mean and standard deviation. All statistical calculations were done using SPSS (Sta-
tistical Package for Social Science). Qualitative data were described using number and percent. Association between
categorical variables was tested using Chi-square test. When 25% of the cells have expected count less than 5, Fisher
exact test was used.
Continuous variables were presented as mean ± SD (standard deviation) for parametric data. For all above
mentioned statistical tests done, the threshold of significance is fixed at 5% level (p-value).
The results were considered:
 Non-significant when the probability of error is more than 5% (p > 0.05).
 Significant when the probability of error is less than 5% (p < 0.05).
 Highly significant when the probability of error is less than 0.1% (p < 0.001). The smaller the p-value obtained,
the more significant are the results.
3. Results
There was only one mortality in Group A due to non cardiac causes 2 days postoperatively. There were no mor-
talities among group B patients. All patients of both groups had intraoperative assessment for the degree of tricuspid
regurge post repair by TEE. All had trivial to mild tricuspid regurge. The following table (Table 3) shows the post-
operative course for both groups.Table 3
Immediate post-operative course.
Group A Group B P value
Need for inotropic support 20 7 >0.05
Mechanical ventilation time 6 ± 3 h 5 ± 2.5 h >0.05
ICU stay 2 ± 0.4 days 2 ± 1.1 days >0.05
Hospital stay 7 ± 2.1 days 8 ± 1.5 days >0.05
ICU: Intensive Care Unit.
Table 4
Echocardiography at discharge.
Degree of tricuspid regurge Group A (62) Group B (18) P value
Trivial 23 12 >0.05
Mild 32 4 >0.05
Moderate 7 2 >0.05
Severe e e >0.05
Table 5
Echocardiography at one year.
Degree of regurge Group A (40) Group B (14) P value
Trivial 5 6 >0.05
Mild 11 4 >0.05
Moderate 20 3 >0.05
Severe 4 1 >0.05
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different grades of tricuspid regurge at discharge (Table 4).
Follow-up was done 1 year post-operatively by echocardiography. 40 patients from group A completed the follow-
up period versus 14 patients from group B. The results are listed in the following table (Table 5).
4. Discussion
Optimal management of tricuspid valve disease remains a challenge among cardiologists and cardiac surgeons
because patients are often asymptomatic [4]. Tricuspid regurge is most commonly functional secondary to left side
pathology with left sided heart failure [5]. Tricuspid valve repair is indicated in symptomatic patients with significant
tricuspid regurge despite optimized medical treatment. Tricuspid repair is also indicated in asymptomatic patients
with significant tricuspid regurge undergoing concomitant cardiac surgery [3,6].
The ideal technique for tricuspid valve repair is still controversial. The DeVega suture technique is a simple
procedure involving the plication of the tricuspid annulus from the anteroseptal to the posteroseptal commissure using
2 continuous sutures over Teflon pledgets [7]. Other investigators have reported however a high incidence of
recurrence particularly in patients with severe annular dilatation and have recommended the use of annuloplasty rings
to obtain a durable repair [8,9].
In our study, there was no statistically significant difference between the DeVega annuloplasty group and the ring
annuloplasty group regarding the early postoperative outcome or even the one year follow-up. The only observed
difference might be the longer operative time in the ring group, which might be attributed to the more complexity of
the procedure. However, the limited number of patients and the short follow-up period are limiting factors.
Another study by Abdelfattah and Omar showed no significant difference at one year between tricuspid repair using
DeVega annuloplasty and band annuloplasty using PTFE [10]. Also, Dokhan et al. studied the outcome of DeVega
annuloplasty and had similar results [11].
We concluded that tricuspid repair using ring annuloplasty has good results, with low risks. However, a larger
number of patients need to be included in the study as well as a longer follow-up period to determine its superiority and
its better long term results compared to the DeVega technique.
Conflict of interest
No conflict of interest.
References
[1] Rankin JS, Hammill BG, Ferguson TB, et al. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg
2006;131:547e57.
[2] Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the task force on the management of
valvular heart disease of the European Society of Cardiology. Eur Heart J 2007;28:230e68.
[3] Bonnow RO, Carabello BA, Chatterjee K, et al. Focused update incorporated into the ACC/AHA 2006 guidelines for the management of
patients with valvular heart disease. Circulation 2008;118:e523e661.
[4] Rizzoli G, Vendramin I, Nesseris G, et al. Biological or mechanical prostheses in tricuspid position? A meta-analysis of intra-institutional
results. Ann Thorac Surg 2004;77:1607e14.
[5] Cohn LF. Tricuspid regurgitation secondary to mitral valve disease: when and how to repair. J Cardiovasc Surg 1994;9:237e41.
[6] Allard M, Boutin C, Burwash IG, et al. Canadian cardiovascular consensus 2004: surgical management of valvular heart disease. Can J
Cardiol 2004;20(Suppl. E):50Ee3E.
[7] Morishita A, Kitamura M, Noji S. Long term results after DeVega annuloplasty. J Cardiovasc Surg (Torino) 2002;43:773e7.
[8] Yoda I, Tani K, Shimono T, et al. Preoperative evaluation and surgical treatment of tricuspid regurgitation associated with acquired valvular
heart disease. The Kay-Boyd method versus the Carpentier - Edwards ring method. J Cardiovasc Surg (Torino) 1990;31:771e7.
[9] Konishi Y, Taksuta N, Mirami K, et al. Comparative study of Kay- boyd's, DeVega's and Carpentier annuloplasty in the management of
functional tricuspid regurgitation. Jpn Circ J 1983;47:1167e72.
[10] Abdelfattah I, Omar A. Early outcome of tricuspid repair for functional tricuspid regurgitation associated with rheumatic mitral valve
disease. Modified flexible band annuloplasty versus suture annuloplasty. J Egypt Soc Cardiothorac Surg 2014;22(3):13e7. http://escts.net/
upload/file/1ff6554604219832c7192492f1debc21.pdf.
[11] Dokhan AL, Ibrahim IM, Alkhateeb Y, Mohamed H. Concomitant repair of moderate tricuspid regurgitation in patients undergoing mitral
valve surgery. J Egypt Soc Cardiothorac Surg 2014;22(3):55e60. http://escts.net/upload/file/9653e8223988bd3b886b0aea4c729f60.pdf.
